Category Specific RSS

News

PYC Therapeutics Moves Toward First Treatment for Blinding Childhood Eye Disease

Australian biotech PYC Therapeutics (ASX:PYC) has taken a major step forward with its lead program, presenting clinical data that signals…

1 year ago

Impact Minerals Accelerates HPA Market Entry with Strategic HiPurA® Acquisition

Australia’s Push To Lead In High Purity Alumina (HPA) Impact Minerals (ASX:IPT) has secured a 50% stake in Alluminous Pty…

1 year ago

Equity Story Acquires Baker Young to Accelerate Retail Stockbroking Expansion

Equity Story Group Taps Booming Advisory Sector Equity Story Group Ltd (ASX:EQS) has taken a major step into full-service wealth…

1 year ago

Condor Confirms 3 Billion Barrel Oil Potential in Tumbes Basin

Independent Resource Estimate Highlights Massive Oil Exploration Upside A new independent assessment has confirmed a best estimate of 3 billion…

1 year ago

Atomo Scales Up HIV Self-Testing Through National Vending Machine Rollout

Federal Funding Unlocks New Health Access Opportunity Atomo Diagnostics (ASX:AT1) has received a $230,000 order from Thorne Harbour Health (THH)…

1 year ago

Spenda Secures $3M Term Loan to Accelerate Growth

Funding Injection Strengthens Spenda’s Push Towards Operational Break-Even Spenda Limited (ASX:SPX) has executed a $3 million term loan facility with…

1 year ago

Argent BioPharma Expands in Europe with German Approval for CannEpil™

Cannabinoid Therapy Gains Foothold in Germany's Epilepsy Market Argent BioPharma (ASX:RGT) has secured approval for its flagship cannabinoid-based epilepsy treatment,…

1 year ago

Koonenberry Gold Strikes High-Grade Gold at Enmore Project

Enmore Gold Project Shows Exploration Potential Koonenberry Gold (ASX:KNB) has returned high-grade gold intercepts from its first diamond drillhole at…

1 year ago

AVJennings Strikes Takeover Deal with AVID Property

Property Market Shift Opens Opportunities Australia’s property sector continues to attract strong investor interest, with major players eyeing strategic acquisitions.…

1 year ago

The RBA sits pat on rates as Federal election, US tariffs beckon

The RBA’s benchmark interest rate was left unchanged at 4.10% at the Bank’s 31 March-1 April Board meeting, with our…

1 year ago